A spectroscopic study of the reaction of NAMI, a novel ruthenium(III) anti-neoplastic complex, with bovine serum albumin

European Journal of Biochemistry

Volumn 267, Issue 4, 2000, Pages 1206-1213

  Messori, Luigi ^a   Orioli, Pierluigi ^a   Vullo, Daniela ^a   Alessio, Enzo ^b   Iengo, Elisabetta ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Albumin; Cancer; Circular dichroism; Ruthenium

Indexed keywords

ANTINEOPLASTIC AGENT; BOVINE SERUM ALBUMIN; IMIDAZOLE DERIVATIVE; RUTHENIUM COMPLEX;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CHEMICAL STRUCTURE; CIRCULAR DICHROISM; COMPLEX FORMATION; DRUG PROTEIN BINDING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ANIMALS; ANTINEOPLASTIC AGENTS; ASCORBIC ACID; CATTLE; CHLORIDES; CIRCULAR DICHROISM; DIALYSIS; DIETHYL PYROCARBONATE; DIMETHYL SULFOXIDE; HISTIDINE; HYDROLYSIS; LIGANDS; ORGANOMETALLIC COMPOUNDS; OXIDATION-REDUCTION; PROTEIN BINDING; RUTHENIUM; RUTHENIUM COMPOUNDS; SERUM ALBUMIN, BOVINE; SPECTROPHOTOMETRY, ATOMIC;

BOVINAE;

EID: 0033952345     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.2000.01121.x     Document Type: Article

References (22)

1. 4 (DMSO) Im] on solid mouse tumors. Anti-Cancer Drugs 3, 25-31.
2. 4 (DMSO) Im], a metal complex of ruthenium with antimetastaic properties Clin. Exp. Metastasis 10, 273-280.
3. 3. Sava, G., Capozzi, I., Bergamo, A., Gagliardi, R., Cocchietto, M., Masiero, L., Onisto, M., Alessio, E., Mestroni, G. & Garbisa, S. (1996) Down-regulation of tumor gelatinase/inhibitor balance and preservation of tumor endothelium by an anti-metastatic rutheium complex. Int. J. Cancer 68 (1), 60-66.
4. 4. Mestroni, G., Alessio, E., Sava, G., Pacor, S., Coluccia, M. & Boccarelli, A. (1994) Water-soluble ruthenium (III)-dimethyl sulfoxide complexes. Chem Behav Pharmaceut Properties, Metal Based Drugs 1, 41-63.
5. 5. Sava, G., Alessio, E., Bergamo, A. & Mestroni, G. (1999) Sulfoxide ruthenium complexes. Non toxic tools for the selective treatment of solid tumor metastases. Topics Bioinorg. Chem. 1, 143-169.
6. 3). Inorg. Chim. Acta 203, 205-217.
7. 4 (DMSO) (Ind)] with apotranferrin: a spectroscopic study. Metal Based Drugs 3, 1-63.
8. 8. Alessio, E., Mestroni, G., Sava, G., Bergamo, A., Coluccia, M. & Messori, L. (1997) Cytotoxic, Mutagenic, and Carcinogenic Potential of Heavy Metals Related to Human Environment (Hadjliadis. N.D., ed), pp. 457-466.
9. 9. Kratz, F., Hartmann, M., Keppler & Messori, L. (1994) The binding properties of two antitumour ruthenium (III) complexes to apotransferrin. J. Biol. Chem. 269, 2581-2588.
10. 10. Kratz, F., Mulinacci, N., Messori, L., Bertini, I. & Keppler, B.K. (1992) Metal ions from the environment to the function in living organism. In Metal Ions in Biology and Medicine (Anastassopoulou, J., Collery, P., Etienne, J.C. & Theophanides, T., eds), Vol. 2, pp. 69-74. John Libbey Eurotext, Paris, France.
11. 11. Kratz, F., Keppler, B.K., Hartmann, M., Messori, L. & Berger, M.R. (1996) Comparison of the antiproliferative activity of two antitumour ruthenium (III) complexes with their apotransferrin and transferrin-bound forms in human colon cancer cell line. Metal Based Drugs 3, 15-23.
12. 12. Kratz, F., Keppler, B.K., Messori, L., Smith, C. & Baker, E.N. (1994) Protein-binding properties of two antitumour Ru (III) complexes to human apotransferrin ans apolactoferrin. Metal Based Drugs 1, 169-173.
13. 13. Smith, C.A., Sutherland-Smith, A.J., Keppler, B.K., Kratz, F. & Baker, E.N. (1996) Binding of ruthenium (III) anti-drugs to human lactoferrin probed by high resolution X-ray crystallographic structure analyses. J. Biol. Inorg. Chem. 1, 424-431.
14. 14. Christendat, D. & Thurnbull, J. (1996) Identification of active site residues of chorismate mutase-prephenate dehydrogenase from Escherichia coli. Biochemistry 35, 4468-4479.
15. 15. Lundblad, R.L. (1995) Techniques in Protein Modification. CRC Press, Boca Raton, FL, USA.
16. 16. Rodger, A. & Nordén, B. (1997). Circular Dichroism and Linear Dichroism. Oxford University Press, Oxford, UK.
17. 17. Keppler, B.K., Rupp, W., Juhl, U.M., Endres, H., Niebl, R. & Balzer, W. (1987) Synthesis, molecular structure, and tumor-inhibiting properties of imidazolium trans-bis (imidazole) tetrachlororuthenate (III) and its methyl-substituted derivaties. Inorg. Chem. 26, 4366-4370.
18. 18. Clarke, M.S. & Stubbs, H. (1987) Metal Ions in Biological Systems (Sigel, H., ed.), Vol. 33. pp. 728-755. Marcel Dekker, New York, USA.
19. 19. Winkler, J.R. & Gray, H.B. (1992) Electron transfer in ruthenium modified proteins. Chem. Rev. 92, 369-379.
20. 20. Sundberg, R.J. & Gupta, G. (1973) Nitrogen-carbon linkage isomerism of histidine in ruthenium ammine complexes. Bioinorg. Chem 3, 39-48.
21. 21. Sava, G., Pacor, S., Bergamo, A., Cocchietto, M., Mestroni, E. & Alessio, E. (1995) Effects of ruthenium complexes on experimental tumors, irrilevance of cytitoxicity for metastasis inhibition. Chem. Biol. Interact. 95, 109-126.
22. 22. Keppler, B.K. (1993) Metal Complexes in Cancer Chemotherapy. Weinheim, Germany.